DPI-221
![]() | |
Identifiers | |
---|---|
| |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C31H38FN3O |
Molar mass | 487.651 |
3D model (JSmol) | |
| |
InChI
| |
DPI-221 is an opioid drug that is used in scientific research. It is a highly selective agonist for the δ-opioid receptor, which produces fewer convulsions than most drugs from this family.[1]
References[]
- ^ Holt JD, Watson MJ, Chang JP, O'Neill SJ, Wei K, Pendergast W, et al. (November 2005). "DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats". The Journal of Pharmacology and Experimental Therapeutics. 315 (2): 601–8. doi:10.1124/jpet.105.090498. PMID 16020629. S2CID 97486165.
Categories:
- Synthetic opioids
- Delta-opioid receptor agonists
- Benzamides
- Piperazines
- Fluoroarenes
- Analgesic stubs